PAX6 and breast cancer: Introduction of OTX2CRISPR at multiple timepoints allowed for identification of previously described phenotypes for OTX2, including effects on eye morphology, RPE pigmentation and gene expression, PR and BC formation, and repression of PAX6 expression.